Follicular lymphoma: 6-year follow-up of the RELEVANCE trialA recent study found the drug combination lenalidomide + rituximab is a durable, effective and safe alternative to the standard regimen combining rituximab and chemotherapy. First of its kind study on the value of Canada’s specialty drug marketNeighbourhood Pharmacies and IQVIA team up to provide quantitative data report on the real value of pharmacy specialty services. Hospital for Sick Children in Toronto reduces surgeries to preserve critical care The hospital says in a release that it has no choice as its ICU has been above 127% capacity for several days. Two provincial privacy watchdogs confirm Sobeys experiencing data breach Quebec's access to information commission confirmed Thursday it received a declaration of a "confidentiality incident'' from the grocer. QUIZ: Test your knowledge of infection prevention and control in community clinics Test your knowledge on policies and procedures that reduce the spread of infectious disease. Dr. Mathieu Nadeau-Vallée: fighting misinformation Dr. Mathieu Nadeau-Vallée was selected by his peers for the Media Engagement Learner Award in the Medical Post Awards. Vitamins A, C and E may cut risk of glaucoma by half Study from Spain finds a 47% reduced risk over time. Dr. Katharine Smart: Speaking out for Canadians—and healthcare workers Dr. Katharine Smart was selected by her peers for the Media Engagement Award – Changemaker in the Medical Post Awards. One-stop shop: New Canadian cardiovascular disease guideline pulls together dozens of recommendations The guideline is an update to a 2018 iteration and adds 48 fresh recommendations. Manitoba announces $200 million to help ease strain on healthcare system The plan includes pay incentives for weekend shifts and money to encourage part-time nurses to switch to full-time. First Previous 779 780 781 782 783 Next Last
